Pharmanex® Pro-B (Capsules) Instructions for Use
Marketing Authorization Holder
Nu Skin Enterprises Rs, LLC (Russia)
Manufactured By
Deseret Laboratories Inc. (USA)
For
NSE Products, Inc. (USA)
Contact Information
Nu Skin Enterprises Rs LLC (Russia)
Dosage Form
| Pharmanex® Pro-B | Capsules: 30 pcs. |
Dosage Form, Packaging, and Product Composition
Capsules transparent; capsule contents – powder of almost white color; weighing 344 mg.
| 1 caps. | |
| Lactobacillus fermentum PCC | 30-90 mg (≥2×109 CFU)* |
Excipients: microcrystalline cellulose – 174-234 mg*, stearic acid – 6 mg, silicon dioxide – 4 mg.
Capsule shell composition: hypromellose, water, carrageenan, potassium chloride.
30 pcs. – plastic bottles (1) – cardboard packs.
* The weight of the ingredients Lactobacillus fermentum PCC and microcrystalline cellulose may vary in different batches depending on the activity and density of the Lactobacillus fermentum preparation to maintain a probiotic dose of ≥2×109 CFU per capsule throughout the shelf life and a total capsule weight of 344 mg.
Therapeutic Category
Dietary supplement – source of probiotic lactobacilli
Properties
A biologically derived product that regulates the balance of intestinal microflora, a probiotic.
It contains a live culture of Lactobacillus fermentum PCC bacteria resistant to the acidic environment of the stomach. Lactobacilli have high adhesion to mucous membranes, which contributes to the formation of a protective surface biolayer on the intestinal walls. They have antagonistic activity against pathogenic and opportunistic microorganisms due to the production of organic acids (mainly lactic acid) and bacteriocins during metabolism.
The anti-inflammatory effect of the drug is due to the inhibition of the synthesis of pro-inflammatory cytokines TNF, γ-interferon, IL-1β, IL-6, IL-12 and stimulation of interleukin-10 synthesis. Exopolysaccharides of Lactobacillus fermentum reduce the severity of oxidative stress by increasing the activity of superoxide dismutase and catalase and reducing the content of malondialdehyde and the activity of myeloperoxidase.
The immunostimulating and immunomodulatory effect of Lactobacillus fermentum is associated with the presence of peptidoglycans and teichoic acids in their cell wall, the formation of arginine and nitric oxide, as well as the prevention of adhesion of pathogenic and opportunistic microorganisms to the intestinal walls and their formation of endotoxin.
Studies have been conducted showing the positive effect of Lactobacillus on increasing insulin sensitivity, vitamin D metabolism, and reducing cholesterol and LDL levels.
Scope of Application
Of Pharmanex® Pro-B product
As a dietary supplement – an additional source of probiotic lactobacilli
- For the prevention and treatment of dysbiosis, incl. associated with antibiotic use;
- As part of complex therapy:
- Inflammatory diseases of the gastrointestinal tract (enteritis, colitis);
- Allergic reactions;
- Irritable bowel syndrome.
ICD codes
| ICD-10 code | Indication |
| A09 | Other and unspecified gastroenteritis and colitis of infectious origin |
| K52.8 | Other specified noninfective gastroenteritis and colitis |
| K58 | Irritable bowel syndrome |
| K63.8 | Other specified diseases of intestine |
| ICD-11 code | Indication |
| 1A40.Z | Infectious gastroenteritis or colitis, unspecified |
| DA42.Z | Gastritis, unspecified |
| DA92.1 | Pneumatosis intestinalis of the small intestine |
| DA98.Z | Polyps of small intestine, unspecified |
| DB31.1 | Pneumatosis of the colon |
| DB36.Z | Certain infections of the colon, unspecified |
| DD91.0Z | Irritable bowel syndrome, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally. Take with a meal to enhance bacterial survival through the gastrointestinal tract.
The standard recommended daily dose for adults and adolescents is one capsule. Do not exceed this dosage.
For use during a course of antibiotic therapy, take the capsule at least 2-3 hours before or after the antibiotic dose to prevent inactivation of the probiotic.
Continue administration for the duration recommended by a healthcare provider, typically for several weeks, to support gut flora restoration.
Swallow the capsule whole with a full glass of water. Do not crush or chew the capsule.
For individuals with difficulty swallowing, the capsule may be opened and the contents mixed with a small amount of cool, non-carbonated liquid or soft food (e.g., yogurt, applesauce) and consumed immediately.
Initiate use only after verifying no contraindications, such as known hypersensitivity to any component. Discontinue use if any adverse reactions occur and seek medical advice.
Store the bottle tightly closed in the original packaging at the recommended temperature to preserve the viability of the live bacteria until the expiration date.
Storage Conditions
The product should be stored at a temperature not exceeding 20°C (68°F), away from heat sources, sunlight, and high humidity.
Shelf Life
Shelf life – 18 months.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer